Orginalny
There are currently no generally accepted systemic treatments that alter the overall course of this disease. Some symptomatic treatments can be helpful for symptoms such as Raynaud's or heartburn, but with the exception of the use of ACE inhibitors to treat scleroderma renal crisis, there have been no clear advances in scleroderma treatments over the past 40 years, according to recent research. Autologous stem cell transplants (HSCT) are being studied and may be helpful for patients with rapidly progressing disease, but at best, this treatment has about a 5% mortality rate.